LEChENIE_INFEKTsII_HELICOBACTER_PYLORI_U_DETEJ_Ko

of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. - Aliment. Pharmacol. Ther., 2004, v.20, p. 1181 -1188.

141.Cremonini F., Di Caro S., Covino M., Armuzzi A., et al. Effect of different probiotic preparations on antiHelicobacter pylori therapy-related side effects: a parallel

group < triple blind < placebo-controlled study. - Am.J.Gastroenterol., 2002, v.97, p.2744-2749.

142.Sykora J., Valeckova K., Amlerova J., Siala K., et al. Effect of specially designed fermented milk product containing probiotic Lactobacillus casei DN-114001 and the eradication of H.pylori. in children - J.Clin.Gastroenterol., 2005, v.39, p.692-698.

143.Uemura N. H.pylori. infection and high risk of gastric cancer - Is improvement of atrophic gastritis by probiotics LG21 possible? - Abstracts of the 6 Western Pacific Helicobacter congress, 2006, Bangkok, p.73.

144.Sachdeva A., Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials.- Eur. J. Gastroenterol. Hepatol., 2009, v.21(1), p.45-53.

145.Boonyaritichaikij S. A trial for prophylaxis of H.pylori. infection in school children using probiotics. - Abstracts of 6th Western Pacific Helicobacter Congress, Bangkok, 2006, p.9.

146.Kawai Т., Takagi A., Uemura N., Inoue K., et al. Randomized double blind trial of the efficacy of Lactobacillus gasseri OLL2716(LG21) for suppression of Helicobacter pylori. - Helicobacter, 2006, v.11, s.2, p.40.

147.Di Mario F., Aragona G., Dal Bo N.,et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicenter study. - Aliment. Pharmacol. Ther., 2006, v.23, p.1077-1086.

148.Ершов Ф.И., Тазулахова Э.Б. Индукторы интерферона - новое поколение иммуномодуляторов. - Terra medica, 1998, № 2, с.2-39.

149.Egan B.J., Marzio L., O'Conner H., O'Morain C. Treatment of Helicobacter pylori infection. - Helicobacter, 2008, v.13,s.1, p.35-40.

150.Thong-Ngam D., Chatsuwan T. Antibacterial activity of Aloe vera, circumin, garlic and plaunotol against Helicobacter pylori - Helicobacter, 2006, v.11, s.2, p.44.

151.Matsushima M., Takagi A., Masui A., Suzuki Т., et al. Growth ingibiting action of cranberry on Helicobacter pylori. - Helicobacter, 2006, v.11, s.2, p.43.

152.Kuo C.J., Guo R.T., Lu I.L., Liu H.G., et al. Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Esherichia coli undecarpenyl pyrophosphate synthases. - J.Biomed. Biotechnol., 2008, 2008:841312.

153.Nishimori I., Onishi S., Takeuchi H.,Supuran C.T. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. - Curr. Pharm.,2008, v.14, p.622-630.

154.Campo S.M.A., Zullo A., Hassan C., Morini S. Antibiotic treatment strategies for Helicobacter pylori infection. - Recent Patents Anti-infect. Drug.Dis., 2007, v.2, p.11-17.

155.Arora S., Czinn S.J. Vaccination as a method of preventing Helicobacter pylori-associated gastric cancer. - Cancer Epidemiol.Biomarkers Prev., 2005, v.14, p.1890-1891.

156.Michetti P., Kreiss C., Kotloff K.L., et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. - Gastroenterology, 1999, v.116, p.804-

157.Bumann D., Metzger W.G., Mansouri E., et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urese A and В from Helicobacter pylori in human volunteers. - Vaccine, 2001, v.20, p.845-852.

158.Malfertheiner P., Schultze V., Del Guidice G., et al. Phase 1 safety and immunogenicity of a three-component H.pylori. vaccine. - Gastroenterology, 2002, v.122, A585.

159.Vajdy M., Singh M., Ugozzoli M., et al. Enhanced mucosal and systemicimmune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. - Immunology, 2003, v.110, p.86-94.

160.Eisenberg J.C., Czinn S.J., Garhart C.A., et al.Protective efficacy of anti-Helicobacter pylori immunity following systematic immunization of neonatal mice. - Infect. Immun, 2003, v.71, p.1820-1827.